Wegovy
FDA-Approved Specifically for Weight Loss
Semaglutide
What is Wegovy?
Wegovy contains the same active ingredient as Ozempic but at a higher dose specifically optimized for weight loss. It is FDA-approved for chronic weight management.
How It Works
Like Ozempic, Wegovy mimics the GLP-1 hormone to reduce hunger and increase feelings of fullness. The higher therapeutic dose is specifically calibrated for maximum weight loss benefit.
Who It Is For
Wegovy is ideal for individuals whose primary goal is weight loss rather than diabetes management. It offers the proven benefits of semaglutide at an optimized dose for weight management.
Clinical Results
Weight Loss Results
Participants in clinical trials lost an average of 15-17% of their body weight over 68 weeks.
Timeline
The dosing schedule gradually increases over 16-20 weeks to minimize side effects. Most patients see significant results by month 4-6.
Source: STEP clinical trial program, FDA approval documentation
Benefits of Wegovy
Why Waiting Can Cost You
Every month of untreated obesity increases your risk of serious health complications. The progression from pre-diabetes to Type 2 diabetes can happen faster than you expect.
Type 2 Diabetes
Pre-diabetes progresses to diabetes in 15-30% of people within 5 years without intervention.
Heart Disease
Obesity significantly increases risk of heart attack, stroke, and cardiovascular death.
Quality of Life
Joint pain, low energy, and reduced mobility impact your ability to be present for family and worship.
Potential Side Effects
Most side effects are mild and improve as your body adjusts to the medication. Our physicians will discuss your individual risk factors and monitor your progress.
Is Wegovy Right for You?
You may be eligible if you have a BMI of 30 or higher, or a BMI of 27 or higher with weight-related health conditions like diabetes, high blood pressure, or high cholesterol.
Your Body Has a Right Over You
Take the first step toward the strength and health you deserve. No stigma. No judgment. Just support.